Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), has announced a nationwide open casting call for the Faces of Natrelle® campaign, seeking women who have undergone breast reconstruction or augmentation to share their stories. The initiative, running through February 28, 2025, extends the Natrelle® For Every BODY platform and aims to promote inclusivity and diversity.
Natrelle®, recognized as the #1 selected breast implant by leading U.S. physicians, offers the largest range of breast implant options. The campaign targets women aged 22 or older who have recently scheduled or undergone Natrelle® procedures. Important safety information highlights that breast implants are not lifetime devices and may require additional surgeries due to complications, including risks of BIA-ALCL cancer and various systemic symptoms.
Allergan Aesthetics, una società di AbbVie (NYSE: ABBV), ha annunciato un casting call nazionale aperto per la campagna Faces of Natrelle®, alla ricerca di donne che hanno subito ricostruzione o aumento del seno per condividere le loro storie. L'iniziativa, attiva fino al 28 febbraio 2025, estende la piattaforma Natrelle® For Every BODY e mira a promuovere inclusività e diversità.
Natrelle®, riconosciuto come l'impianto mammario più selezionato dai principali medici negli Stati Uniti, offre la più ampia gamma di opzioni per impianti mammari. La campagna si rivolge a donne di almeno 22 anni che hanno recentemente programmato o subito procedure Natrelle®. Importanti informazioni sulla sicurezza evidenziano che gli impianti mammari non sono dispositivi a vita e potrebbero richiedere interventi chirurgici aggiuntivi a causa di complicazioni, inclusi i rischi di tumore BIA-ALCL e vari sintomi sistemici.
Allergan Aesthetics, una empresa de AbbVie (NYSE: ABBV), ha anunciado una convocatoria abierta a nivel nacional para la campaña Faces of Natrelle®, en busca de mujeres que hayan sufrido reconstrucción o aumento de senos para compartir sus historias. La iniciativa, que estará activa hasta el 28 de febrero de 2025, amplía la plataforma Natrelle® For Every BODY y tiene como objetivo promover la inclusividad y la diversidad.
Natrelle®, reconocido como el implante mamario más seleccionado por los principales médicos de EE. UU., ofrece la mayor variedad de opciones de implantes mamarios. La campaña está dirigida a mujeres de 22 años o más que hayan programado o se hayan sometido recientemente a procedimientos Natrelle®. Información importante de seguridad destaca que los implantes mamarios no son dispositivos de por vida y pueden requerir cirugías adicionales debido a complicaciones, incluidos los riesgos de cáncer BIA-ALCL y diversos síntomas sistémicos.
알레르간 미용학, 애브비(뉴욕증권거래소: ABBV)의 한 회사, 는 Faces of Natrelle® 캠페인을 위한 전국적인 오디션 공고를 발표하며, 유방 재건 또는 확대 수술을 받은 여성들이 자신의 이야기를 나누기를 요청하고 있습니다. 이 이니셔티브는 2025년 2월 28일까지 진행되며, Natrelle® For Every BODY 플랫폼을 확장하고 포용성과 다양성을 촉진하는 것을 목표로 하고 있습니다.
Natrelle®은 미국의 주요 의사들에 의해 가장 많이 선택된 유방 임플란트로, 가장 다양한 유방 임플란트 옵션을 제공합니다. 이 캠페인은 최근에 Natrelle® 절차를 예약하거나 시행한 22세 이상의 여성들을 대상으로 하고 있습니다. 중요한 안전 정보는 유방 임플란트가 평생 사용되는 장치가 아니며, BIA-ALCL 암과 다양한 전신 증상을 포함한 합병증으로 인해 추가 수술이 필요할 수 있음을 강조합니다.
Allergan Aesthetics, une entreprise d'AbbVie (NYSE: ABBV), a annoncé un appel à candidatures national ouvert pour la campagne Faces of Natrelle®, cherchant des femmes qui ont subi une reconstruction ou un agrandissement mammaire pour partager leurs histoires. L'initiative, qui se déroule jusqu'au 28 février 2025, étend la plateforme Natrelle® For Every BODY et vise à promouvoir l'inclusivité et la diversité.
Natrelle®, reconnu comme l'implant mammaire le plus sélectionné par des médecins de premier plan aux États-Unis, offre la plus large gamme d'options d'implants mammaires. La campagne cible les femmes âgées de 22 ans ou plus qui ont récemment programmé ou subi des procédures Natrelle®. Des informations importantes sur la sécurité soulignent que les implants mammaires ne sont pas des dispositifs à vie et peuvent nécessiter des interventions chirurgicales supplémentaires en raison de complications, y compris les risques de cancer BIA-ALCL et divers symptômes systémiques.
Allergan Aesthetics, ein Unternehmen von AbbVie (NYSE: ABBV), hat einen landesweiten offenen Casting-Call für die Kampagne Faces of Natrelle® angekündigt, in dem Frauen gesucht werden, die sich einer Brustrekonstruktion oder -vergrößerung unterzogen haben, um ihre Geschichten zu teilen. Die Initiative, die bis zum 28. Februar 2025 läuft, erweitert die Natrelle® For Every BODY-Plattform und zielt darauf ab, Inklusion und Vielfalt zu fördern.
Natrelle®, bekannt als das am häufigsten gewählte Brustimplantat führender US-Ärzte, bietet die größte Auswahl an Brustimplantat-Optionen. Die Kampagne richtet sich an Frauen ab 22 Jahren, die kürzlich Natrelle®-Verfahren geplant oder durchgeführt haben. Wichtige Sicherheitsinformationen heben hervor, dass Brustimplantate keine lebenslangen Geräte sind und möglicherweise aufgrund von Komplikationen, einschließlich der Risiken von BIA-ALCL-Krebs und verschiedenen systemischen Symptomen, zusätzliche Operationen erforderlich machen.
- Market leadership position as #1 selected breast implant by leading U.S. physicians
- Brand expansion through nationwide marketing campaign
- Product carries significant health risks including cancer (BIA-ALCL)
- Additional surgeries likely required due to complications
- Product not considered a lifetime device, indicating ongoing replacement costs
- Consumers Can Apply Today for a Chance to be Featured in an Upcoming Campaign by Natrelle® and Share Their Personal Stories.
- Natrelle® is the #1 Selected Breast Implant by Leading
U.S. Physicians* Offering the Largest Range of Options For Every Curve, Every Shape, For Every BODY.
"The Faces of Natrelle® campaign is more than just celebrating physical beauty," said Carrie Strom, Senior Vice President, AbbVie and President, Global Allergan Aesthetics. "We're honoring the strength, resilience, and uniqueness of the women who use our products. Through this campaign, our goal is to empower women who are considering breast surgery by demystifying treatment, encouraging transparency, and celebrating the diversity of every curve, every shape, and every BODY."
The Faces of Natrelle® casting call is open now through February 28, 2025 closing at 11:59 p.m. EDT. Women 22 years of age or older who have recently scheduled or undergone a Natrelle® breast augmentation or reconstruction are encouraged to learn more about eligibility and how to apply at Faces.Natrelle.com. Intended for
To learn more about treatment with Natrelle® or to find a provider, please visit natrelle.com, and follow along on Instagram @natrellebreastaugmentation and @natrellebreastreconstruction.
*Based on surgeon survey data, January 2021 (N = 114) and Plastics Monthly Tracker DOF Jan. 2021.
Natrelle® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery.
Breast implants have been associated with the development of a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more commonly in patients with textured breast implants than smooth implants, although rates are not well defined. Some patients have died from BIA-ALCL.
Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.
Who can get breast implants?
Natrelle® Breast Implants are approved for the following:
- Breast augmentation for women at least 22 years old for silicone-filled implants and for women at least 18 years old for saline-filled implants. Breast augmentation includes primary breast augmentation to increase the breast size and revision surgery to correct or improve the result of a primary breast augmentation
- Breast reconstruction. This includes primary breast reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. This also includes revision surgery to correct or improve the result of a primary breast reconstruction
Who should NOT get breast implants?
Breast implant surgery should NOT be performed in:
- Women with active infection anywhere in their body
- Women with existing cancer or precancer of their breast who have not received adequate treatment for those conditions
- Women who are currently pregnant or nursing
What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:
- Autoimmune diseases (eg, lupus and scleroderma)
- A weakened immune system (eg, taking medications to decrease the body's immune response)
- Planned chemotherapy or radiation therapy following breast implant placement
- Conditions or medications that interfere with wound healing and blood clotting
- Reduced blood supply to breast tissue
- Clinical diagnosis of depression or other mental health disorders, including body dysmorphic disorder and eating disorders
- Those with a diagnosis of depression or other mental health disorders should wait for resolution or stabilization of these conditions prior to undergoing breast implantation surgery
What else should I consider?
- There is a Boxed Warning for breast implants. Please see bold text at beginning
- Many changes to your breasts following implantation are irreversible. If you later choose to have your implants removed and not replaced, you may experience dimpling, puckering, wrinkling, or other cosmetic changes, which may be permanent
- Breast implantation is likely not a one-time surgery. The longer implants are in place, the greater the potential risk for complications. You will likely need additional surgeries on your breasts due to complications or unacceptable cosmetic results. Thus, you should also consider the complication rates for later (revision) surgery since you may experience these risks in the future
- Cancer treatments and surgery will affect the outcome and timing of breast reconstruction
- Breast implants may affect your ability to breastfeed, either by reducing or eliminating milk production
- Rupture of a silicone-filled breast implant is most often silent. Even if you have no symptoms, you should have your first ultrasound or MRI at 5 to 6 years after your initial implant surgery and then every 2 to 3 years thereafter regardless of whether your implants are for augmentation or reconstruction. If you have symptoms of or uncertain ultrasound results for breast implant rupture, an MRI is recommended. Additional imaging may be required depending on your medical history and status. The health consequences of a ruptured silicone gel-filled breast implant have not been fully established
- Routine screening mammography for breast cancer will be more difficult, and implants may rupture during the procedure. Perform self-examination every month for cancer screening and ask your surgeon to help you distinguish the implant from your breast tissue. Lumps, persistent pain, swelling, hardening, or changes in implant shape should be reported to your surgeon and possibly evaluated with imaging
What are key complications with breast implants?
Key complications include reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture (severe scar tissue around the implant). Other complications include breast pain, swelling, asymmetry, wrinkling/rippling, implant malposition nipple complications, hypertrophic scarring, and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at www.allergan.com/products.
To report a problem with Natrelle® Breast Implants, please call Allergan® at 1-800-624-4261.
The sale and distribution of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Contacts
Allergan Aesthetics Media:
Ember Garrett
+1 (949) 413-6091
Garrett_ember@allergan.com
AbbVie Investors:
Liz Shea
+1 (847) 935-2211
Liz.Shea@abbvie.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-invites-consumers-to-join-the-faces-of-natrelle-campaign-302369295.html
SOURCE AbbVie
FAQ
What is the deadline for ABBV's Faces of Natrelle® campaign submissions?
What are the eligibility requirements for ABBV's Faces of Natrelle® campaign?
What major health risks are associated with ABBV's Natrelle® breast implants?
What is Natrelle®'s market position in ABBV's breast implant segment?
